In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
Astera Labs Inc (NASDAQ: ALAB) closed the day trading at $194.5 down -0.66% from the previous closing price of $195.8. In other words, the price has decreased by -$0.66 from its previous closing price. On the day, 4.88 million shares were traded. ALAB stock price reached its highest trading level at $195.86 during the session, while it also had its lowest trading level at $186.1197.
Ratios:
For a better understanding of ALAB, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 30.32 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 153.68. For the most recent quarter (mrq), Quick Ratio is recorded 10.55 and its Current Ratio is at 11.10. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, TD Cowen on October 01, 2025, initiated with a Hold rating and assigned the stock a target price of $200.
On July 22, 2025, Northland Capital Downgraded its rating to Market Perform which previously was Outperform but kept the price unchanged to $120.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 02 ’25 when ALBA MANUEL sold 183,000 shares for $173.27 per share. The transaction valued at 31,707,713 led to the insider holds 385,863 shares of the business.
Mazzara Philip sold 10,000 shares of ALAB for $1,886,956 on Aug 28 ’25. The General Counsel and Secretary now owns 161,573 shares after completing the transaction at $188.70 per share. On Sep 02 ’25, another insider, CASA ALAMEDA 2007, LLC, who serves as the Director of the company, bought 33,000 shares for $182.20 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALAB now has a Market Capitalization of 32874821632 and an Enterprise Value of 31296841728. As of this moment, Astera’s Price-to-Earnings (P/E) ratio for their current fiscal year is 341.05, and their Forward P/E ratio for the next fiscal year is 92.15. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 6.45. For the stock, the TTM Price-to-Sale (P/S) ratio is 53.39 while its Price-to-Book (P/B) ratio in mrq is 28.46. Its current Enterprise Value per Revenue stands at 51.683 whereas that against EBITDA is 670.929.
Stock Price History:
The Beta on a monthly basis for ALAB is 1.44, which has changed by 3.0155864 over the last 52 weeks, in comparison to a change of 0.17342639 over the same period for the S&P500. Over the past 52 weeks, ALAB has reached a high of $262.90, while it has fallen to a 52-week low of $47.12. The 50-Day Moving Average of the stock is 5.00%, while the 200-Day Moving Average is calculated to be 69.92%.
Shares Statistics:
Over the past 3-months, ALAB traded about 5.87M shares per day on average, while over the past 10 days, ALAB traded about 7953360 shares per day. A total of 166.21M shares are outstanding, with a floating share count of 127.24M. Insiders hold about 23.45% of the company’s shares, while institutions hold 61.19% stake in the company. Shares short for ALAB as of 1757894400 were 9621313 with a Short Ratio of 1.64, compared to 1755216000 on 8997848. Therefore, it implies a Short% of Shares Outstanding of 9621313 and a Short% of Float of 7.870000000000001.
Earnings Estimates
Its stock is currently analyzed by 14.0 different market analysts. The consensus estimate for the next quarter is $0.42, with high estimates of $0.46 and low estimates of $0.39.
Analysts are recommending an EPS of between $1.62 and $1.55 for the fiscal current year, implying an average EPS of $1.58. EPS for the following year is $2.1, with 16.0 analysts recommending between $2.88 and $1.8.
Revenue Estimates
13 analysts predict $206.39M in revenue for. The current quarter. It ranges from a high estimate of $208.1M to a low estimate of $201.52M. As of. The current estimate, Astera Labs Inc’s year-ago sales were $113.09MFor the next quarter, 13 analysts are estimating revenue of $216.51M. There is a high estimate of $222.3M for the next quarter, whereas the lowest estimate is $209.58M.
A total of 16 analysts have provided revenue estimates for ALAB’s current fiscal year. The highest revenue estimate was $805M, while the lowest revenue estimate was $762.47M, resulting in an average revenue estimate of $776.58M. In the same quarter a year ago, actual revenue was $396.29MBased on 15 analysts’ estimates, the company’s revenue will be $1.04B in the next fiscal year. The high estimate is $1.29B and the low estimate is $972.5M.
